Triple

T22404611
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EU) No 536/2014 E553848 entity
Predicate shortName P43 FINISHED
Object EU Clinical Trials Regulation NE NERFINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: EU Clinical Trials Regulation | Statement: [Regulation (EU) No 536/2014, shortName, EU Clinical Trials Regulation]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: EU Clinical Trials Regulation
Context triple: [Regulation (EU) No 536/2014, shortName, EU Clinical Trials Regulation]
  • A. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • B. EU regulations chosen
    EU regulations are binding legislative acts of the European Union that apply directly and uniformly in all member states, shaping common policies and legal standards across the EU.
  • C. European Union medical device regulations
    European Union medical device regulations are a comprehensive set of legal and technical requirements governing the safety, performance, quality management, and market approval of medical devices within EU member states.
  • D. ICH E8 General Considerations for Clinical Trials
    ICH E8 General Considerations for Clinical Trials is an international guideline that outlines fundamental principles and quality considerations for the design, conduct, and evaluation of clinical studies across all phases of drug development.
  • E. ICH E6 Good Clinical Practice
    ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (2 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69e11e4da7048190b4387d422a9a0de5 completed April 16, 2026, 5:37 p.m.
NER Named-entity recognition batch_69f158b6762c8190991fc14c5ca8e609 completed April 29, 2026, 1:02 a.m.
Created at: April 16, 2026, 8:46 p.m.